Journal article

Changes in biodistribution on Ga-68-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression

Martin H Cherk, Grace Kong, Rodney J Hicks, Michael S Hofman

Cancer Imaging | E-MED | Published : 2018

DOI: 10.1186/s40644-018-0136-x

Citation metrics

6Web of Science
8Scopus

Keywords

Science & Technology
Affinity
Organometallic Compounds
Oncology
Male
Life Sciences & Biomedicine
Lu-177-Octreotate
Tissue Distribution
Guidelines
Middle Aged
Female
Octreotide
Humans
Radiopharmaceuticals
Positron Emission Tomography
Toxicity
Ga-68
Pet/ct
Neuroendocrine Tumors
Octreotate
Neoplasm Metastasis
Somatostatin
Aged
Receptor Radionuclide Therapy
Dotatate
Neuroendocrine Tumour
Positron Emission Tomography Computed Tomography
Radiology, Nuclear Medicine & Medical Imaging
Adult
False Positive Reactions